DR

DRUG

0.26%
50K shares11 Sept(T+4)
Loading chart...

Fundamentals

P/E Ratio23.9
52W Range$7.64 - $9.27
Dividend Yield3.86%

Related in Sector

No related stocks

Historical Data31 days

DateShort %Gross Short
11 Sept0.26%
28 Aug
27 Aug
26 Aug
25 Aug
24 Aug
21 Aug
20 Aug
19 Aug
18 Aug
17 Aug
14 Aug

Beta Global Health (DRUG) Short Interest Summary

Beta Global Health (DRUG) currently has 0.26% of its shares sold short (50 thousand shares, worth approximately $454K), based on ASIC short position data reported on 11 September 2026 (T+4 reporting lag). That makes DRUG the #386 most shorted stock on the ASX most shorted list.

Recent DRUG Short Position History

DateShort %Short SharesClose Price
11 Sept 20260.26%0.1M
31 July 20260.00%0.0M$8.69
21 July 20260.00%0.0M$8.53
10 July 20260.34%0.1M

DRUG Short Selling — Frequently Asked Questions

What is Beta Global Health (DRUG)'s current short interest?

Beta Global Health (DRUG) currently has a short interest of 0.26% of total shares outstanding. This means 0.26% of DRUG's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.

Is DRUG heavily shorted on the ASX?

DRUG has a relatively low short interest of 0.26%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.

What does short interest mean for DRUG investors?

Short interest in DRUG shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.26%, DRUG's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.

Where does this DRUG short data come from?

Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for DRUG.